Biomarkers of proteolytic damage following traumatic brain injury.
about
Traumatic white matter injury and glial activation: from basic science to clinics.Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substratesNeuroproteomics: a biochemical means to discriminate the extent and modality of brain injury.Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside.Serum-based protein biomarkers in blast-induced traumatic brain injury spectrum disorder.Antioxidant and antiapoptotic effects of darbepoetin-α against traumatic brain injury in rats.Proteomic identification of biomarkers of traumatic brain injury.Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injuryCurrent status of fluid biomarkers in mild traumatic brain injuryCaspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage.Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injuryBiochemical, structural, and biomarker evidence for calpain-mediated cytoskeletal change after diffuse brain injury uncomplicated by contusion.Calpain as a therapeutic target in traumatic brain injury.Predictive biomarkers of recovery in traumatic brain injury.Use of biomarkers for diagnosis and management of traumatic brain injury patients.The role of calpains in traumatic brain injury.Biomarkers in traumatic brain injury: a review.Metabolic crisis after traumatic brain injury is associated with a novel microdialysis proteome.Calpastatin overexpression limits calpain-mediated proteolysis and behavioral deficits following traumatic brain injury.Phage display for identification of serum biomarkers of traumatic brain injuryBiomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury.Biomarkers in the clinical diagnosis and management of traumatic brain injury.Biofluid biomarkers of traumatic brain injury.Neuroproteomics Studies: Challenges and Updates.CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluid.The protective effect of 2-mercaptoethane sulfonate (MESNA) against traumatic brain injury in rats.Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury.Novel differential neuroproteomics analysis of traumatic brain injury in rats.Investigation of the effect of hyperglycemia on intracerebral hemorrhage by proteomic approaches.Potential Alzheimer's Disease Therapeutics Among Weak Cysteine Protease Inhibitors Exhibit Mechanistic Differences Regarding Extent of Cathepsin B Up-Regulation and Ability to Block Calpain.Identification and preliminary validation of novel biomarkers of acute hepatic ischaemia/reperfusion injury using dual-platform proteomic/degradomic approaches
P2860
Q30816308-78632538-4BCB-4531-AE03-CEB95558B82DQ33608570-A1AE485D-2A63-40C1-91DB-D0858D4470D3Q34193737-E588C74B-5A6C-4960-949D-53C78E14839BQ35580549-DEE4DC82-2E17-4892-B591-F10979D183C4Q36079583-8710EDC7-9D03-4865-AF18-CB3024077413Q36220699-D59451CA-41D6-4406-9AE5-385366895B4FQ36227974-EB7C8FAA-C4FC-4BB5-83CA-9DC21C610B08Q36242794-DDC98CC5-8E2D-4917-B1FF-7B429E85147AQ36424343-142FD29A-1000-4C29-BE51-8031A93B3EA1Q36534046-4CCF8D0A-E696-4E8E-AF98-8FE570C7B10AQ36731362-3FF17F00-B6A5-4FB7-A1CB-3CB9DE480C14Q37425364-0B083FDD-C82F-437A-9834-A4800846532CQ37686765-54F8C90F-13D4-4CC7-97BE-5E1D1F7C4DE9Q38004986-FFD8F75A-2C09-42F5-8A5F-CC2ADD865233Q38089787-C2509BE7-BC55-4C77-B6C7-3C4E2734E61EQ38181174-D2607343-AABE-4802-A99C-B3CBDE23AB96Q38623128-A606E071-EEB5-4479-B352-F4C01766120DQ42151783-0B7EB8AD-CD39-4CDA-BD4A-707E41621077Q42229910-6385B373-6E2B-4D2F-8D02-20FB46B42767Q42382458-48716E5E-A2D0-48E2-BEB0-0C377DA100BAQ44923505-1ED8A821-D85A-4107-86F4-89C416C27530Q45061432-254AB88E-4C73-47C7-A3A4-07BD7CC9A9A7Q47605675-11634D30-F725-4659-899F-83D7D9718142Q47721773-106D57C9-344B-4101-9975-B15356AA8E3BQ47803888-BF9E3BFB-A781-428F-A85F-74A72BF1FC2CQ48342070-782D0F4A-B3F5-4476-BE0D-97A361DC941DQ48377471-97F52CF6-0E3E-4058-B3D9-6A1FD9756CB0Q48487232-D7D6FFB1-B482-42AE-9F61-9C7638E69B76Q54551805-03FCA26C-E285-4652-9B33-30A190505B14Q55363568-D38AC0A3-2F68-4DA0-AE6D-DD80B8423099Q58115152-B6FDC9B0-7B4A-47A5-A61D-76AE01EAE553
P2860
Biomarkers of proteolytic damage following traumatic brain injury.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biomarkers of proteolytic damage following traumatic brain injury.
@ast
Biomarkers of proteolytic damage following traumatic brain injury.
@en
type
label
Biomarkers of proteolytic damage following traumatic brain injury.
@ast
Biomarkers of proteolytic damage following traumatic brain injury.
@en
prefLabel
Biomarkers of proteolytic damage following traumatic brain injury.
@ast
Biomarkers of proteolytic damage following traumatic brain injury.
@en
P2860
P921
P1433
P1476
Biomarkers of proteolytic damage following traumatic brain injury.
@en
P2093
Jose A Pineda
Ronald L Hayes
P2860
P304
P356
10.1111/J.1750-3639.2004.TB00054.X
P577
2004-04-01T00:00:00Z